Free Trial

Corbus Pharmaceuticals (CRBP) SEC Filings & 10K Form

Corbus Pharmaceuticals logo
$16.33 +0.25 (+1.55%)
(As of 11:01 AM ET)

Recent Corbus Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/14/2024
6:48 PM
Corbus Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
11/14/2024
5:41 PM
Corbus Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G
11/14/2024
2:09 PM
Corbus Pharmaceuticals (Subject)
Cormorant Asset Management, LP (Filed by)
Form SC 13G/A
11/12/2024
1:34 PM
Corbus Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/12/2024
8:37 AM
Adage Capital Management, L.P. (Filed by)
Corbus Pharmaceuticals (Subject)
Form SC 13G/A
11/07/2024
3:58 PM
Corbus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
7:41 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
10:28 AM
Corbus Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
6:51 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
Corbus Pharmaceuticals (Subject)
Form SC 13G
10/15/2024
3:19 PM
Corbus Pharmaceuticals (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G/A
09/24/2024
3:04 PM
Chen Bihua (Reporting)
Corbus Pharmaceuticals (Issuer)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
3:44 PM
CATLIN AVERY W (Reporting)
Corbus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2024
3:52 PM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
3:45 PM
Corbus Pharmaceuticals (Issuer)
Kung Winston (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/20/2024
3:48 PM
Corbus Pharmaceuticals (Issuer)
Kung Winston (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
7:15 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
3:42 PM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2024
4:58 PM
Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
4:59 PM
Corbus Pharmaceuticals (Issuer)
Moran Sean F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
8:21 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
4:25 PM
Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
4:25 PM
Corbus Pharmaceuticals (Subject)
Moran Sean F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
3:30 PM
Corbus Pharmaceuticals (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:31 PM
CATLIN AVERY W (Reporting)
Corbus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:32 PM
Corbus Pharmaceuticals (Issuer)
Jenkins John Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
6:08 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2024
3:39 PM
Corbus Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/20/2024
3:30 PM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
7:00 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
7:30 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
8:17 AM
Corbus Pharmaceuticals (Issuer)
Moran Sean F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
3:58 PM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
3:59 PM
Corbus Pharmaceuticals (Filer)
Form DEFA14A
03/22/2024
4:05 PM
Corbus Pharmaceuticals (Filer)
Form PRE 14A
03/20/2024
11:15 PM
Corbus Pharmaceuticals (Filer)
Form EFFECT
03/20/2024
4:07 PM
Corbus Pharmaceuticals (Filer)
Form 424B3
03/20/2024
4:10 PM
Corbus Pharmaceuticals (Filer)
Form 10-K/A
03/20/2024
4:13 PM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
3:52 PM
Corbus Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/12/2024
4:19 PM
Corbus Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
Breaking News: Tesla headed to $500… (Ad)

That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.

So to claim your free digital copy today, simply follow this link and enter your email address. 
03/12/2024
7:15 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
4:34 PM
Chen Bihua (Reporting)
Corbus Pharmaceuticals (Issuer)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:13 PM
Corbus Pharmaceuticals (Issuer)
Smethurst Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:07 PM
Corbus Pharmaceuticals (Issuer)
Smethurst Dominic (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/14/2024
3:45 PM
Corbus Pharmaceuticals (Subject)
K2 HealthVentures Equity Trust LLC (Filed by)
Form SC 13G/A
02/14/2024
2:19 PM
Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
2:26 PM
Corbus Pharmaceuticals (Issuer)
Moran Sean F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
3:47 PM
Corbus Pharmaceuticals (Subject)
Cormorant Global Healthcare Master Fund, LP (Filed by)
Form SC 13G
02/05/2024
7:12 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2024
7:55 PM
Corbus Pharmaceuticals (Filer)
Form 8-K/A
02/01/2024
4:27 PM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2024
4:09 PM
Corbus Pharmaceuticals (Filer)
Form 424B5
01/31/2024
8:16 AM
Corbus Pharmaceuticals (Filer)
Form S-3MEF
01/30/2024
7:40 PM
Corbus Pharmaceuticals (Filer)
Form 424B5
01/30/2024
7:41 PM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2024
5:07 PM
Corbus Pharmaceuticals (Issuer)
HOLMER ALAN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
3:56 PM
Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
3:18 PM
Chen Bihua (Reporting)
Corbus Pharmaceuticals (Issuer)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/30/2024
3:23 PM
Chen Bihua (Reporting)
Corbus Pharmaceuticals (Issuer)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
3:40 PM
Corbus Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G
01/29/2024
6:30 AM
Corbus Pharmaceuticals (Filer)
Form 424B3
01/29/2024
6:31 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
7:45 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CRBP) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners